Genomic Vision is entering an exciting phase of growth and innovation, driven by the increasing demand for sophisticated and targeted advanced therapies and a greater regulatory focus on safety on therapeutic safety.

With our innovative molecular combing technology and our experienced leadership team, we believe Genomic Vision is well-positioned to capitalize on the rapidly growing demand for highly accurate, fast, and accessible solutions for genome characterization of advanced therapies.

Our mission

At Genomic Vision, we deliver high-quality genomic solutions to improve quality control and bioproduction standards of advanced gene therapies at scale. Collaborating with our partners and customers, we strive to unlock the full potential of advanced therapies with the ultimate goal of improving the lives of patients worldwide.

We strongly believe in the endless possibilities of genomic discovery. We are motivated by the belief that every question that sparks curiosity in our minds can be answered through the exploration of genomics. This drives us to relentlessly seek answers and deliver solutions that can revolutionize healthcare.

Our team

Supervisory Board

Mohammad Afshar

Executive Board

Aaron Bensimon
PhD., Co-founder, CEO

Lionel Seltz

Exclusive European distribution agreement with CliniSciences S.A.S

France, Germany, United Kingdom, Ireland, Spain, Portugal, Switzerland, Italy, Denmark, Belgium, Austria, Netherlands, Luxembourg, Sweden, Finland, Norway, Iceland and Morocco